02. 12. 2024

Phesi announces AI-driven Trial Accelerator™ hits critical milestone with data from 100 million patients

Read more
01. 16. 2024

Phesi releases 2023 analysis of clinical development; breast cancer remains most studied disease area for third year

Read more
10. 15. 2023

Phesi launches Health Check and Trial Rescue Service to save at-risk trials and bring drugs to market faster

Phesi announces the launch of its new Health Check and Trial Rescue Service. The free of charge service will enable sponsors to submit their protocols to Phesi for a review, offering real-time insights and forecasting within ten working days

Read more
09. 07. 2023

Phesi and Krystelis collaborate to launch new Diversity, Equity, and Inclusion Data Service for clinical development

Phesi announces its partnership with Krystelis, a world leading provider of medical writing and clinical trial transparency services, to launch its new Diversity, Equity, and Inclusion (DEI) Data Service. The new service harnesses data from Phesi Trial Accelerator™ and Krystelis’ writing services to empower sponsors to improve diversity from the trial planning stage onwards

Read more